Hepatotoxic effects due to pyrrolizidine alkaloid N-oxides.
D000284:Administration, Oral; D000818:Animals; D005260:Female; D007274:Injections, Intraperitoneal; D007413:Intestinal Mucosa / Q000378:metabolism; D007928:Lethal Dose 50; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D010087:Oxides / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000506:poisoning; D010944:Plants; D011763:Pyrrolizidine Alkaloids / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000506:poisoning; D051381:Rats; D012756:Sheep; D013045:Species Specificity; D013997:Time Factors
D010087:Oxides; D011763:Pyrrolizidine Alkaloids